The “Obesity Paradox” in Patients With HFpEF With or Without Comorbid Atrial Fibrillation
Background: Overweight and mildly obese individuals have a lower risk of death than their normal-weight counterparts; this phenomenon is termed “obesity paradox.” Whether this “obesity paradox” exists in patients with heart failure (HF) or can be modified by comorbidities is still controversial. Our...
Main Authors: | Linjuan Guo, Xiao Liu, Peng Yu, Wengen Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.743327/full |
Similar Items
-
Worsening Renal Function and Adverse Outcomes in Patients with HFpEF with or without Atrial Fibrillation
by: Linjuan Guo, et al.
Published: (2023-09-01) -
Aldosterone Antagonism in Atrial Fibrillation: Implications for AF‐Predominant HFpEF
by: Jennifer E. Ho
Published: (2020-09-01) -
Is atrial fibrillation in HFpEF a distinct phenotype? Insights from multiparametric MRI and circulating biomarkers
by: Abhishek Dattani, et al.
Published: (2024-02-01) -
Is excessive ventricular irregularity predictive of rehospitalization in patients with permanent AF and HFpEF?
by: Corentin Chaumont, et al.
Published: (2023-06-01) -
The “obesity paradox” in patients with atrial fibrillation: Insights from the Gulf SAFE registry
by: Yan-Guang Li, et al.
Published: (2022-11-01)